Wal-Mart's Generics Hit Pharma Stocks

The retailer's move to offer many generics for $4 a prescription took a bite out of pharmaceutical stocks. And it's another salve for Wal-Mart's PR

When Wal-Mart Stores (WMT) disclosed on Sept. 21 that it will make 291 generic drugs available for only $4 per prescription, the news slammed many pharmacy retailers and generic drug stocks. The announcement also was one more step in the company's carefully orchestrated campaign to improve its image.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.